| Application number | Title of the application | Filing Date | Status |
|---|
| 07/903604 | ANDROSTENE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS | Jun 23, 1992 | Abandoned |
Array
(
[id] => 3099434
[patent_doc_number] => 05314904
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-24
[patent_title] => 'Pharmaceutical compositions containing rifaximin for treatment of vaginal infections'
[patent_app_type] => 1
[patent_app_number] => 7/899421
[patent_app_country] => US
[patent_app_date] => 1992-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5233
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/314/05314904.pdf
[firstpage_image] =>[orig_patent_app_number] => 899421
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/899421 | Pharmaceutical compositions containing rifaximin for treatment of vaginal infections | Jun 15, 1992 | Issued |
Array
(
[id] => 2920406
[patent_doc_number] => 05234954
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-08-10
[patent_title] => 'Treatment of hyperlipidemia with 15-keto-prostaglandin compounds'
[patent_app_type] => 1
[patent_app_number] => 7/899171
[patent_app_country] => US
[patent_app_date] => 1992-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6066
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/234/05234954.pdf
[firstpage_image] =>[orig_patent_app_number] => 899171
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/899171 | Treatment of hyperlipidemia with 15-keto-prostaglandin compounds | Jun 14, 1992 | Issued |
| 07/897756 | COMPOSITION CONTAINING DIOXABICYCLO [3.3.0]OCTANE DERIVATIVE | Jun 11, 1992 | Abandoned |
Array
(
[id] => 3475370
[patent_doc_number] => 05428028
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-27
[patent_title] => 'Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor'
[patent_app_type] => 1
[patent_app_number] => 7/897119
[patent_app_country] => US
[patent_app_date] => 1992-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22506
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/428/05428028.pdf
[firstpage_image] =>[orig_patent_app_number] => 897119
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/897119 | Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor | Jun 10, 1992 | Issued |
Array
(
[id] => 3016259
[patent_doc_number] => 05340836
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-08-23
[patent_title] => 'Composition and method for treatment of vaginal yeast infections'
[patent_app_type] => 1
[patent_app_number] => 7/892615
[patent_app_country] => US
[patent_app_date] => 1992-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 10144
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/340/05340836.pdf
[firstpage_image] =>[orig_patent_app_number] => 892615
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/892615 | Composition and method for treatment of vaginal yeast infections | May 31, 1992 | Issued |
Array
(
[id] => 3094741
[patent_doc_number] => 05298497
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-03-29
[patent_title] => 'Method for preventing onset of hypertension employing a cholesterol lowering drug'
[patent_app_type] => 1
[patent_app_number] => 7/891243
[patent_app_country] => US
[patent_app_date] => 1992-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7882
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/298/05298497.pdf
[firstpage_image] =>[orig_patent_app_number] => 891243
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/891243 | Method for preventing onset of hypertension employing a cholesterol lowering drug | May 31, 1992 | Issued |
| 07/890283 | THIAZOLIDINE DERIVATIVES HAVING ANTI-HYPERTENSIVE ACTIVITY AND THEIR THERAPEUTIC USE | May 25, 1992 | Abandoned |
| 07/886961 | INHIBITORS OF TESTOSTERONE 5 ALPHA-REDUCTASE ACTIVITY | May 20, 1992 | Abandoned |
| 07/886270 | PROTECTIVE PROSTAGLANDINS FOR USE IN CONJUNCTION WITH CHEMOTHERAPEUTIC AGENTS | May 19, 1992 | Abandoned |
Array
(
[id] => 3057509
[patent_doc_number] => 05338732
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-08-16
[patent_title] => 'Megestrol acetate formulation'
[patent_app_type] => 1
[patent_app_number] => 7/882218
[patent_app_country] => US
[patent_app_date] => 1992-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2690
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/338/05338732.pdf
[firstpage_image] =>[orig_patent_app_number] => 882218
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/882218 | Megestrol acetate formulation | May 12, 1992 | Issued |
| 07/881521 | PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS | May 11, 1992 | Abandoned |
Array
(
[id] => 3028504
[patent_doc_number] => 05317015
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-31
[patent_title] => 'Azacyclic bisphosphonates as anticholesterolemic agents'
[patent_app_type] => 1
[patent_app_number] => 7/877574
[patent_app_country] => US
[patent_app_date] => 1992-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6591
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/317/05317015.pdf
[firstpage_image] =>[orig_patent_app_number] => 877574
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/877574 | Azacyclic bisphosphonates as anticholesterolemic agents | Apr 30, 1992 | Issued |
Array
(
[id] => 3118936
[patent_doc_number] => 05380752
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-01-10
[patent_title] => 'Method for preventing oxidation of crystalline steroid alcohols in cells, lipoproteins, and chylomicrons'
[patent_app_type] => 1
[patent_app_number] => 7/877826
[patent_app_country] => US
[patent_app_date] => 1992-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3326
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/380/05380752.pdf
[firstpage_image] =>[orig_patent_app_number] => 877826
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/877826 | Method for preventing oxidation of crystalline steroid alcohols in cells, lipoproteins, and chylomicrons | Apr 30, 1992 | Issued |
| 07/876495 | USE OF RETINOIC ACID TO TREAT VAGINAL ATROPHY | Apr 29, 1992 | Abandoned |
Array
(
[id] => 2962039
[patent_doc_number] => 05264428
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-11-23
[patent_title] => 'Use of stigmasta-4-en-3-one in the treatment of androgen dependent diseases'
[patent_app_type] => 1
[patent_app_number] => 7/876131
[patent_app_country] => US
[patent_app_date] => 1992-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2484
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/264/05264428.pdf
[firstpage_image] =>[orig_patent_app_number] => 876131
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/876131 | Use of stigmasta-4-en-3-one in the treatment of androgen dependent diseases | Apr 28, 1992 | Issued |
Array
(
[id] => 3014590
[patent_doc_number] => 05308861
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-03
[patent_title] => 'Therapeutic agent for treating atherosclerosis of mammals'
[patent_app_type] => 1
[patent_app_number] => 7/875367
[patent_app_country] => US
[patent_app_date] => 1992-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10158
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/308/05308861.pdf
[firstpage_image] =>[orig_patent_app_number] => 875367
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/875367 | Therapeutic agent for treating atherosclerosis of mammals | Apr 28, 1992 | Issued |
| 07/875277 | CONTRACEPTION SYSTEM AND METHOD | Apr 27, 1992 | Abandoned |
| 07/872272 | CONTRACEPTION IN FEMALE PRIMATES WITHOUT AFFECTING THE MENSTRUAL CYCLE | Apr 21, 1992 | Abandoned |
Array
(
[id] => 2951621
[patent_doc_number] => 05221690
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-06-22
[patent_title] => 'Increasing the choroidal blood flow'
[patent_app_type] => 1
[patent_app_number] => 7/867359
[patent_app_country] => US
[patent_app_date] => 1992-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2304
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/221/05221690.pdf
[firstpage_image] =>[orig_patent_app_number] => 867359
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/867359 | Increasing the choroidal blood flow | Apr 12, 1992 | Issued |